X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (16) 16
chemotherapy (11) 11
humans (11) 11
index medicus (11) 11
cancer (9) 9
aged (8) 8
female (8) 8
lung cancer, non-small cell (8) 8
male (8) 8
respiratory system (8) 8
lung neoplasms - drug therapy (7) 7
lung neoplasms - pathology (6) 6
carcinoma, non-small-cell lung - drug therapy (5) 5
medicine & public health (5) 5
middle aged (5) 5
non-small cell lung cancer (5) 5
targeted cancer therapy (5) 5
aged, 80 and over (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
biomedicine, general (4) 4
life sciences (4) 4
lung cancer (4) 4
mutation (4) 4
neoplasm staging (4) 4
oncology, experimental (4) 4
open-label (4) 4
research (4) 4
tyrosine (4) 4
adult (3) 3
analysis (3) 3
azd9291 (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
carcinoma, non-small-cell lung - pathology (3) 3
care and treatment (3) 3
crizotinib (3) 3
epidermal growth factor (3) 3
hematology, oncology and palliative medicine (3) 3
lung neoplasms - genetics (3) 3
lung neoplasms - mortality (3) 3
management (3) 3
metastasis (3) 3
prognosis (3) 3
prospective studies (3) 3
pulmonary/respiratory (3) 3
resistance (3) 3
treatment outcome (3) 3
[sdv]life sciences [q-bio] (2) 2
adenocarcinoma (2) 2
aged patients (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
bronchoscopy (2) 2
carcinoma, non-small-cell lung - mortality (2) 2
ceritinib (2) 2
critical care medicine (2) 2
deoxycytidine - administration & dosage (2) 2
deoxycytidine - analogs & derivatives (2) 2
disease progression (2) 2
early access program (2) 2
egfr (2) 2
elderly (2) 2
elderly patients (2) 2
erlotinib (2) 2
follow-up studies (2) 2
france - epidemiology (2) 2
gemcitabine (2) 2
impact (2) 2
induction chemotherapy (2) 2
inhibitors (2) 2
lung adenocarcinoma (2) 2
lung cancer, small cell (2) 2
lymphomas (2) 2
mechanisms (2) 2
medical prognosis (2) 2
medical research (2) 2
medicine, experimental (2) 2
multicenter (2) 2
mutant nsclc (2) 2
neoplasm recurrence, local (2) 2
original (2) 2
original article (2) 2
paclitaxel plus bevacizumab (2) 2
phase-iii (2) 2
phase-iii trial (2) 2
precancerous conditions - pathology (2) 2
receptor, epidermal growth factor - genetics (2) 2
risk factors (2) 2
small cell lung carcinoma - drug therapy (2) 2
small cell lung carcinoma - pathology (2) 2
survival (2) 2
survival analysis (2) 2
survival rate (2) 2
taxoids - administration & dosage (2) 2
therapy (2) 2
trial (2) 2
tyrosine-kinase inhibitors (2) 2
vinorelbine (2) 2
1st-line treatment (1) 1
2nd-line treatment (1) 1
[ sdv ] life sciences [q-bio] (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
TARGETED ONCOLOGY, ISSN 1776-2596, 12/2017, Volume 12, Issue 6, pp. 841 - 842
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s11523-017-0534-1 
ONCOLOGY | Lung cancer, Non-small cell
Journal Article
Lung Cancer, ISSN 0169-5002, 07/2018, Volume 121, pp. 25 - 29
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 9, pp. 8253 - 8262
To assess efficacy and tolerance of EGFR tyrosine-kinase inhibitors (TKIs) for advanced EGFR-mutated non-small cell lung cancer (NSCLC) in octogenarians.... 
Targeted therapies | Gerotarget | Tyrosine-kinase inhibitors | Elderly | Egfr | Non-small cell lung cancer | Life Sciences | Chemical Sciences | Cancer
Journal Article
Journal Article
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 12/2019, Volume 71, Issue 12, pp. 2100 - 2111
Objective Immune checkpoint inhibitors (ICIs) for cancer therapy frequently induce immune‐related adverse effects (IRAEs). Therefore, most patients with... 
Life Sciences
Journal Article
Targeted Oncology, ISSN 1776-2596, 8/2018, Volume 13, Issue 4, pp. 501 - 507
The prognosis of patients with non-small cell lung cancer (NSCLC) who develop leptomeningeal metastasis (LM) is poor.To assess the clinical efficacy of... 
Biomedicine, general | Medicine & Public Health | Oncology | ONCOLOGY | TKIS | RESISTANCE | CARCINOMATOSIS | MUTANT NSCLC | MUTATIONS | AZD9291 | Epidermal growth factor | Metastasis | Mutation | Targeted cancer therapy | Medical prognosis | Lung cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.